Company intelligence / Profile preview

Event Capital Strategies

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

Event Capital Strategies is a private investment and operations firm based in New York, focused on the healthcare, life sciences, and medical technology sectors, with an emphasis on innovation-driven market disruption. It acts as a strategic investor and company builder, supporting portfolio companies to accelerate growth and value creation across areas like medication management, orthopedics, diagnostics, healthcare IT/services, and life sciences. ECS does not develop its own therapeutics or devices.

Industry: Investors

Partnerships

SK Capital Partners (co-investment in Spectrum Vascular)

Beyond the preview

Go deeper on Event Capital Strategies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Event Capital Strategies.

Explore the full profile